Sooma
Helsinki, FI · Founded 2013 · 23 employees on LinkedIn · 4 known investors
Sooma Medical develops and manufactures transcranial direct current stimulation (tDCS) devices for treating major depressive disorder, fibromyalgia, and chronic neuropathic pain without medication. The company serves clinics, hospitals, and universities globally through neuromodulation technology approved for clinical use and research.
Founders & leadership
Sooma was founded in 2013 by Tuomas Neuvonen.
TN
Tuomas NeuvonenCTO
AH
Andreas HartlepCEO
MN
Mika NikanderCOO
Investors · 4
Competitors · 2
by search overlap
Flow Neuroscience26 shared keywordsFlow develops technology-based mental health solutions to address depression symptoms and wellness. The company serves individuals seeking mental health treatment through science-backed approaches.
neurocare group19 shared keywordsneurocare group operates a network of over 20 clinics across Europe, the United States, and Australia offering personalized mental health treatments such as TMS, neurofeedback, and tDCS for conditions including depression, ADHD, OCD, and sleep disorders. It also provides a Digital Therapy Platform and an online academy that trains third-party clinicians in its treatment protocols.
Companies competing with Sooma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sooma do?
- Sooma Medical develops and manufactures transcranial direct current stimulation (tDCS) devices for treating major depressive disorder, fibromyalgia, and chronic neuropathic pain without medication. The company serves clinics, hospitals, and universities globally through neuromodulation technology approved for clinical use and research.
- Who founded Sooma?
- Sooma was founded by Tuomas Neuvonen in 2013.
- Who are Sooma's investors?
- Sooma's investors include Innovestor Ventures, Lifeline Ventures, Verge HealthTech Fund, Voima Ventures.
- Where is Sooma headquartered?
- Sooma is headquartered in Helsinki, FI.